文献速递重症综合管理与镇静镇痛呼吸衰竭与机械通气

选择性消化道去污染对接受机械通气的危重患者院内死亡率的影响:一项随机临床试验

Effect of Selective Decontamination of the Digestive Tract on Hospital Mortality in Critically Ill Patients Receiving Mechanical Ventilation: A Randomized Clinical Trial.
PubMed 文献 · JAMA · 2022-01-01
一句话结论在接受机械通气的危重患者中,与不含SDD的标准治疗相比,SDD未显著降低院内死亡率,但效应估计的置信区间包含具有临床重要性的获益。

该集群交叉随机临床试验在澳大利亚19个ICU招募5982例接受机械通气的成人,比较选择性消化道去污染(SDD)与标准治疗。SDD组接受含黏菌素、妥布霉素和制霉菌素的口腔 paste 及胃内混悬液每6小时一次、持续整个机械通气期间,另加4天静脉抗生素;对照组接受标准治疗。主要终点90天内院内死亡率SDD组27.0%(753/2791) vs 标准治疗组29.1%(928/3191),平均差-1.7%(95%CI -4.8%至1.3%),OR 0.91(95%CI 0.82-1.02),P=0.12,未达统计学显著。8项预设次要终点中6项无显著差异;SDD组新发抗生素耐药菌(ARO)培养阳性23.1% vs 34.6%(绝对差-11.0%,95%CI -14.7%至-7.3%),新发血培养阳性5.6% vs 8.1%(绝对差-1.95%,95%CI -3.5%至-0.4%),新发艰难梭菌感染0.5% vs 0.9%(绝对差-0.24%,95%CI -0.6%至0.1%)。生态学评估中,SDD在第一和第二期间新发ARO比例变化未显示非劣效。

要点

  • SDD组院内死亡率27.0%(753/2791) vs 标准治疗组29.1%(928/3191),平均差-1.7%(95%CI -4.8%至1.3%),OR 0.91(95%CI 0.82-1.02),P=0.12,未达统计学显著。
  • SDD组新发ARO培养阳性23.1% vs 标准治疗组34.6%,绝对差-11.0%(95%CI -14.7%至-7.3%);新发血培养阳性5.6% vs 8.1%,绝对差-1.95%(95%CI -3.5%至-0.4%)。
  • SDD组新发艰难梭菌感染0.5% vs 标准治疗组0.9%,绝对差-0.24%(95%CI -0.6%至0.1%)。
  • 8项预设次要终点中6项无显著差异;SDD方案为口腔 paste 及胃内混悬液(含黏菌素、妥布霉素、制霉菌素)每6小时一次、持续机械通气期间,加4天静脉抗生素。
  • 生态学评估8599例中,SDD在第一和第二期间新发ARO比例变化未显示非劣效(第一期间-3.3% vs -1.59%,平均差-1.71%,单侧97.5%CI -∞至4.31%;第二期间0.88% vs 0.55%,平均差-0.32%,单侧97.5%CI -∞至5.47%)。

适用人群与场景

  • 澳大利亚19个ICU中接受机械通气的危重成人,2018年4月至2021年5月招募,最终随访2021年8月。
  • 生态学评估纳入参与ICU的8599例患者,2017年5月至2021年8月。

处置流程与药物剂量

  • SDD组(n=2791):口腔 paste 及胃内混悬液(含黏菌素、妥布霉素、制霉菌素)每6小时一次,持续整个机械通气期间,另加4天静脉抗生素(具有适当抗菌谱)。
  • 对照组(n=3191):接受不含SDD的标准治疗。

研究设计与关键结果

  • 设计:集群、交叉、随机临床试验,19个ICU随机分配采用或不采用SDD策略,2个交替12个月周期,中间3个月间隔期。
  • 主要终点:90天内院内死亡率SDD组27.0%(753/2791) vs 标准治疗组29.1%(928/3191),平均差-1.7%(95%CI -4.8%至1.3%),OR 0.91(95%CI 0.82-1.02),P=0.12。
  • 新发ARO培养阳性:SDD组23.1% vs 标准治疗组34.6%,绝对差-11.0%(95%CI -14.7%至-7.3%)。
  • 新发血培养阳性:SDD组5.6% vs 标准治疗组8.1%,绝对差-1.95%(95%CI -3.5%至-0.4%)。
  • 新发艰难梭菌感染:SDD组0.5% vs 标准治疗组0.9%,绝对差-0.24%(95%CI -0.6%至0.1%)。
  • 8项预设次要终点中6项无显著差异。
  • 生态学评估:SDD在第一期间新发ARO比例变化-3.3% vs -1.59%,平均差-1.71%(单侧97.5%CI -∞至4.31%);第二期间0.88% vs 0.55%,平均差-0.32%(单侧97.5%CI -∞至5.47%),预设非劣效界值2%,未显示非劣效。

证据类型、等级与局限

  • 证据类型:集群交叉随机临床试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在接受机械通气的危重患者中,与不含SDD的标准治疗相比,SDD未显著降低院内死亡率,但效应估计的置信区间包含具有临床重要性的获益。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Whether selective decontamination of the digestive tract (SDD) reduces mortality in critically ill patients remains uncertain.

OBJECTIVE: To determine whether SDD reduces in-hospital mortality in critically ill adults.

DESIGN, SETTING, AND PARTICIPANTS: A cluster, crossover, randomized clinical trial that recruited 5982 mechanically ventilated adults from 19 intensive care units (ICUs) in Australia between April 2018 and May 2021 (final follow-up, August 2021). A contemporaneous ecological assessment recruited 8599 patients from participating ICUs between May 2017 and August 2021.

INTERVENTIONS: ICUs were randomly assigned to adopt or not adopt a SDD strategy for 2 alternating 12-month periods, separated by a 3-month interperiod gap. Patients in the SDD group (n = 2791) received a 6-hourly application of an oral paste and administration of a gastric suspension containing colistin, tobramycin, and nystatin for the duration of mechanical ventilation, plus a 4-day course of an intravenous antibiotic with a suitable antimicrobial spectrum. Patients in the control group (n = 3191) received standard care.

MAIN OUTCOMES AND MEASURES: The primary outcome was in-hospital mortality within 90 days. There were 8 secondary outcomes, including the proportion of patients with new positive blood cultures, antibiotic-resistant organisms (AROs), and Clostridioides difficile infections. For the ecological assessment, a noninferiority margin of 2% was prespecified for 3 outcomes including new cultures of AROs.

RESULTS: Of 5982 patients (mean age, 58.3 years; 36.8% women) enrolled from 19 ICUs, all patients completed the trial. There were 753/2791 (27.0%) and 928/3191 (29.1%) in-hospital deaths in the SDD and standard care groups, respectively (mean difference, -1.7% [95% CI, -4.8% to 1.3%]; odds ratio, 0.91 [95% CI, 0.82-1.02]; P = .12). Of 8 prespecified secondary outcomes, 6 showed no significant differences. In the SDD vs standard care groups, 23.1% vs 34.6% had new ARO cultures (absolute difference, -11.0%; 95% CI, -14.7% to -7.3%), 5.6% vs 8.1% had new positive blood cultures (absolute difference, -1.95%; 95% CI, -3.5% to -0.4%), and 0.5% vs 0.9% had new C difficile infections (absolute difference, -0.24%; 95% CI, -0.6% to 0.1%). In 8599 patients enrolled in the ecological assessment, use of SDD was not shown to be noninferior with regard to the change in the proportion of patients who developed new AROs (-3.3% vs -1.59%; mean difference, -1.71% [1-sided 97.5% CI, -∞ to 4.31%] and 0.88% vs 0.55%; mean difference, -0.32% [1-sided 97.5% CI, -∞ to 5.47%]) in the first and second periods, respectively.

CONCLUSIONS AND RELEVANCE: Among critically ill patients receiving mechanical ventilation, SDD, compared with standard care without SDD, did not significantly reduce in-hospital mortality. However, the confidence interval around the effect estimate includes a clinically important benefit.

TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02389036.

来源:JAMA,查看原文。版权归原作者所有。

参考来源

  1. Myburgh JA, Seppelt IM, Goodman F, et al. Effect of Selective Decontamination of the Digestive Tract on Hospital Mortality in Critically Ill Patients Receiving Mechanical Ventilation: A Randomized Clinical Trial. JAMA. 2022. PMID: 36286097. doi:10.1001/jama.2022.17927

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。